Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
Reolink Black Friday Sale: Save up to 40% off on Top Security Solutions
FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results
Trip.com Group Limited Reports Unaudited Third Quarter of 2024 Financial Results
TONY BUZBEE SUED FOR EXTORTION
Canada Releases its 2024 New Wheat Crop Report
Tuya Reports Third Quarter 2024 Unaudited Financial Results

